Medtronic Revenue Recognized from Contract Liabilities increased by 513.6% to $135.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $108.00M to $135.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Consistent recognition of deferred revenue indicates a healthy pipeline of service delivery and stable business operations.
This metric tracks the portion of revenue recognized during the period that was previously recorded as deferred revenue...
Commonly analyzed for SaaS and subscription-based business models.
isrg_contract_liability_revenue_recognized| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $84.00M | $76.00M | $32.00M | $87.00M | $129.00M | $124.00M | $72.00M | $78.00M | $108.00M | $121.00M | $22.00M | $135.00M |
| QoQ Change | — | -9.5% | -57.9% | +171.9% | +48.3% | -3.9% | -41.9% | +8.3% | +38.5% | +12.0% | -81.8% | +513.6% |
| YoY Change | — | — | — | +3.6% | +69.7% | +42.5% | -44.2% | — | -12.9% | +68.1% | -71.8% | +25.0% |